1Zehnder C,Glück Z,Descoeudres C,et al.Human recombinant erythropoietin in anaemic patients on maintenance haemodialysis:Secondary effects of the increase of haemoglobin[J].Nephrol Dial Transplant,1988,3(5):657-660.
2Casadevall N,Nataf J,Viron B,et al.Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin[J].N Engl J Med,2002,346:469-475.
3Rossert J,Casadevall N,Eckardt KU.Anti-erythropoietin antibodies and pure red cell aplasia[J].J Am Soc Nephrol,2004,15(2):398-406.
4Weber G,Gross J,Kromminga A,et al.Allergic skin and systemic reactions in a patient with pure red cell aplasia and anti-erythropoietin antibodies challenged with different epoetins[J].J Am Soc Nephrol,2002,13(9):2 381-2 383.
5Verhelst D,Rossert J,Casadevall N,et al.Treatment of erythropoietin induced pure red cell aplasia:a retrospective study[J].Lancet,2004,363(9423):1 768-1 771.
10[1]Jacobs K,Shoemaker C,Rudersdorf R,et al.Isolation and characterization of genomic and cDNA clones of human erythropoietin[J].Nature,1985,313(6005):806-810.
